Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites
Marina Sherif Fam, Christine Adel Sedky, Nancy Osama Turky, Hans-Georg Breitinger, Ulrike Breitinger
Scientific Reports, doi:10.1038/s41598-023-31764-9
SARS-CoV-2 has been responsible for the major worldwide pandemic of COVID-19. Despite the enormous success of vaccination campaigns, virus infections are still prevalent and effective antiviral therapies are urgently needed. Viroporins are essential for virus replication and release, and are thus promising therapeutic targets. Here, we studied the expression and function of recombinant ORF3a viroporin of SARS-CoV-2 using a combination of cell viability assays and patch-clamp electrophysiology. ORF3a was expressed in HEK293 cells and transport to the plasma membrane verified by a dot blot assay. Incorporation of a membrane-directing signal peptide increased plasma membrane expression. Cell viability tests were carried out to measure cell damage associated with ORF3a activity, and voltage-clamp recordings verified its channel activity. The classical viroporin inhibitors amantadine and rimantadine inhibited ORF3a channels. A series of ten flavonoids and polyphenolics were studied. Kaempferol, quercetin, epigallocatechin gallate, nobiletin, resveratrol and curcumin were ORF3a inhibitors, with IC 50 values ranging between 1 and 6 µM, while 6-gingerol, apigenin, naringenin and genistein were inactive. For flavonoids, inhibitory activity could be related to the pattern of OH groups on the chromone ring system. Thus, the ORF3a viroporin of SARS-CoV-2 may indeed be a promising target for antiviral drugs. Coronaviruses (CoVs) belong to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae 1 . They are subdivided into four different genera named α-, β-, γ-, and δ-CoVs 2 . Coronaviruses have been known to infect humans 2-4 , usually causing mild respiratory infections such as a common cold. However, in the past 20 years, two major outbreaks occurred due to crossover of animal β-coronavirus to humans 5 . In 2002-03 humans were infected by bat coronavirus resulting in severe acute respiratory syndrome coronavirus (SARS-CoV) and in 2019, a novel coronavirus of bat origin that had spread to humans, had been discovered in Wuhan, China 6 . This new virus, named SARS-CoV-2, is a member of the β-coronavirus family and is responsible for the ongoing pandemic of COVID-19 1, 7, 8 . SARS-CoVs are enveloped, positive sense single-stranded RNA viruses, with a genome of approximately 30 kb arranged into 14 open reading frames (ORF) encoding 31 proteins [8] [9] [10] [11] . Spike (S), envelope (E), membrane (M) and nucleoprotein (N) are the four structural proteins forming the virus capsid. The S protein binds to the host receptor through the receptor-binding domain in the S1 subunit, while S2 subunit is responsible for membrane fusion 8 . The E protein belongs to the class of viroporins, integral membrane proteins functioning as ion channels and promoting virus release. It was found to be expressed in the ER and the Golgi apparatus forming an ion channel allowing the efflux of cations Na + , K + and Ca 2+ , and is required for pathogenesis and..
Author contributions M.S.F.: design of work, data acquisition and analysis, interpretation of data, revising the manuscript. C.A.S.: data acquisition and analysis, interpretation of data, revising the manuscript. N.O.T.: data acquisition and analysis, interpretation of data, revising the manuscript. H.G.B.: conception, design of work, data acquisition and analysis, interpretation of data, drafting and revising the manuscript. U.B.: conception, design of work, data acquisition and analysis, interpretation of data, drafting, writing and revising the manuscript. All authors have read and approved the submitted manuscript.
Competing interests The authors declare no competing interests.
References
Abba, Hassim, Hamzah, Noordin, Antiviral activity of resveratrol against human and animal viruses, Adv. Virol
Aboubakr, In vitro antiviral activity of clove and ginger aqueous extracts against feline calicivirus, a surrogate for human norovirus, J. Food Prot,
doi:10.4315/0362-028X.JFP-15-593Agrawal, Agrawal, Blunden, Quercetin: antiviral significance and possible COVID-19 integrative considerations, Nat. Prod. Comm,
doi:10.1177/1934578X20976293Arshad, SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression, bioRxiv
Bhowmik, Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches, Infect. Genet. Evol,
doi:10.1016/j.meegid.2020.104451Breitinger, Ali, Sticht, Breitinger, Inhibition of SARS CoV envelope protein by flavonoids and classical viroporin inhibitors, Front. Microbiol,
doi:10.3389/fmicb.2021.692423Breitinger, Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels, J. Gen. Virol,
doi:10.1099/jgv.0.001571Breitinger, Farag, Ali, Breitinger, Patch-clamp study of hepatitis C p7 channels reveals genotype-specific sensitivity to inhibitors, Biophys. J
Breitinger, Farag, Sticht, Breitinger, Viroporins, Structure, function, and their role in the life cycle of SARS-CoV-2, Int. J. Biochem. Cell Biol,
doi:10.1016/j.biocel.2022.106185Castano-Rodriguez, Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis,
doi:10.1128/mBio.02325-17Chan, The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function, Int. J. Biochem. Cell Biol,
doi:10.1016/j.biocel.2009.04.019Chang, Wang, Yeh, Shieh, Chiang, Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines, J. Ethnopharmacol,
doi:10.1016/j.jep.2012.10.043Chen, Insights into the anti-inflammatory and antiviral mechanisms of resveratrol, Mediat. Inflamm,
doi:10.1155/2022/7138756Chen, Lo, Ma, Li, Expression and membrane integration of SARS-CoV E protein and its interaction with M protein, Virus Genes,
doi:10.1007/s11262-009-0341-6Chen, Moriyama, Chang, Ichinohe, Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome, Front. Microbiol,
doi:10.3389/fmicb.2019.00050Cione, Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation, Molecules,
doi:10.3390/molecules25010063De Wit, Van Doremalen, Falzarano, Munster, SARS and MERS: recent insights into emerging coronaviruses, Nat. Rev. Microbiol,
doi:10.1038/nrmicro.2016.81Drago, Nicola, Ossola, De Vecchi, In vitro antiviral activity of resveratrol against respiratory viruses, J. Chemother,
doi:10.1179/joc.2008.20.3.393Duff, Ashley, The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers, Virology,
doi:10.1016/0042-6822(92)91239-qFarag, Breitinger, El-Azizi, Breitinger, The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1β, Biochim. Biophys. Acta Mol. Basis Dis
Fleming, Managing influenza: amantadine, rimantadine and beyond, Int. J. Clin. Pract
Freundt, The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death, J. Virol,
doi:10.1128/JVI.01662-09Gligorijevic, Molecular mechanisms of possible action of phenolic compounds in COVID-19 protection and prevention, Int. J. Mol. Sci
Gonzalez, Carrasco, Viroporins, None, FEBS Lett
Gorbalenya, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat. Microbiol,
doi:10.1038/s41564-020-0695-zGriffin, Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel, Hepatology
Griffin, The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug Amantadine, FEBS Lett
Hayati, 6]-Gingerol inhibits chikungunya virus infection by suppressing viral replication, Biomed. Res. Int,
doi:10.1155/2021/6623400Issa, Merhi, Panossian, Salloum, Tokajian, SARS-CoV-2 and ORF3a: nonsynonymous mutations, functional domains, and viral pathogenesis,
doi:10.1128/mSystems.00266-20Jennings, Parks, Curcumin as an antiviral agent, Viruses
Jimenez-Guardeno, The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis, PLoS Pathog,
doi:10.1371/journal.ppat.1004320Jing, Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel, Proc. Natl. Acad. Sci. U. S. A,
doi:10.1073/pnas.0804958105Kanjanasirirat, High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents, Sci. Rep
Kanzawa, Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation, FEBS Lett,
doi:10.1016/j.febslet.2006.11.046Kaushik, Jangra, Kundu, Yadav, Kaushik, Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus, Virusdisease,
doi:10.1007/s13337-020-00584-0Kern, Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs, bioRxiv
Kien, Ma, Gaisenband, Nal, Microbial Pathogenesis: Infection and Immunity
Kongpichitchoke, Hsu, Huang, Number of hydroxyl groups on the B-ring of flavonoids affects their antioxidant activity and interaction with phorbol ester binding site of PKCδ C1B domain: in vitro and in silico studies, J. Agric. Food Chem,
doi:10.1021/acs.jafc.5b00312Law, The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells, J. Gen. Virol,
doi:10.1099/vir.0.80813-0Lebedeva, Theoretical and experimental study of interaction of macroheterocyclic compounds with ORF3a of SARS-CoV-2, Sci. Rep,
doi:10.1038/s41598-021-99072-8Lim, Ng, Tam, Liu, Human coronaviruses: a review of virus-host interactions, Diseases
Mahrosh, Mustafa, An in silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals, Environ. Dev. Sustain,
doi:10.1007/s10668-021-01373-5Miao, ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation, Dev. Cell,
doi:10.1016/j.devcel.2020.12.010Moghadamtousi, A review on antibacterial, antiviral, and antifungal activity of curcumin, Biomed. Res. Int,
doi:10.1155/2014/186864Naqvi, Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach, Biochim. Biophys. Acta Mol. Basis Dis,
doi:10.1016/j.bbadis.2020.165878Nieto-Torres, Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome, Virology,
doi:10.1016/j.virol.2015.08.010Nieva, Madan, Carrasco, Viroporins: structure and biological functions, Nat. Rev. Microbiol,
doi:10.1038/nrmicro2820Oso, Adeoye, Olaoye, Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases, J. Biomol. Struct. Dyn,
doi:10.1080/07391102.2020.1813630Padhan, Minakshi, Towheed, Jameel, Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation, J. Gen. Virol,
doi:10.1099/vir.0.83665-0Padhan, Severe acute respiratory syndrome coronavirus ORF3a protein interacts with caveolin, J. Gen. Virol,
doi:10.1099/vir.0.82856-0Panche, Diwan, Chandra, Flavonoids: an overview, J. Nutr. Sci
Qu, ORF3a-mediated incomplete autophagy facilitates severe acute respiratory syndrome coronavirus-2 replication, Front. Cell Dev. Biol,
doi:10.3389/fcell.2021.716208Redondo, Zaldívar-López, Garrido, Montoya, SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns, Front. Immunol
Regla-Nava, Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates, J. Virol,
doi:10.1128/JVI.03566-14Salom, Hill, Lear, Degrado, pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus, Biochemistry,
doi:10.1021/bi001799uSchwarz, Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus, Planta Med,
doi:10.1055/s-0033-1360277Scott, Griffin, Viroporins: structure, function and potential as antiviral targets, J. Gen. Virol,
doi:10.1099/vir.0.000201Siu, Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC, FASEB J,
doi:10.1096/fj.201802418RSu, Yu, Zhou, SARS-CoV-2 ORF3a induces incomplete autophagy via the unfolded protein response, Viruses
Tahmasebi, Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients, J. Cell Physiol
Teoh, The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis, Mol. Biol. Cell,
doi:10.1091/mbc.E10-04-0338Torres, Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein, Protein Sci,
doi:10.1110/ps.062730007Tungmunnithum, Thongboonyou, Pholboon, Yangsabai, Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview, Medicines (Basel)
Vakulenko, Deviatkin, Drexler, Lukashev, Modular evolution of coronavirus genomes, Viruses
Verdia-Baguena, Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids, Virology,
doi:10.1016/j.virol.2012.07.005Zhou, Efficacy of ion-channel inhibitors amantadine, memantine and rimantadine for the treatment of SARS-CoV-2 in vitro, Viruses,
doi:10.3390/v13102082{ 'indexed': {'date-parts': [[2023, 4, 4]], 'date-time': '2023-04-04T05:31:46Z', 'timestamp': 1680586306786},
'reference-count': 94,
'publisher': 'Springer Science and Business Media LLC',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2023, 4, 1]],
'date-time': '2023-04-01T00:00:00Z',
'timestamp': 1680307200000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0'},
{ 'start': { 'date-parts': [[2023, 4, 1]],
'date-time': '2023-04-01T00:00:00Z',
'timestamp': 1680307200000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0'}],
'funder': [ { 'DOI': '10.13039/501100003009',
'name': 'Science and Technology Development Fund',
'doi-asserted-by': 'publisher',
'award': ['45420']},
{ 'DOI': '10.13039/501100007637',
'name': 'German University in Cairo',
'doi-asserted-by': 'crossref'}],
'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False},
'abstract': '<jats:title>Abstract</jats:title><jats:p>SARS-CoV-2 has been responsible for the major '
'worldwide pandemic of COVID-19. Despite the enormous success of vaccination campaigns, virus '
'infections are still prevalent and effective antiviral therapies are urgently needed. '
'Viroporins are essential for virus replication and release, and are thus promising '
'therapeutic targets. Here, we studied the expression and function of recombinant ORF3a '
'viroporin of SARS-CoV-2 using a combination of cell viability assays and patch-clamp '
'electrophysiology. ORF3a was expressed in HEK293 cells and transport to the plasma membrane '
'verified by a dot blot assay. Incorporation of a membrane-directing signal peptide increased '
'plasma membrane expression. Cell viability tests were carried out to measure cell damage '
'associated with ORF3a activity, and voltage-clamp\xa0recordings verified its channel '
'activity. The classical viroporin inhibitors amantadine and rimantadine inhibited ORF3a '
'channels. A series of ten flavonoids and polyphenolics were studied. Kaempferol, quercetin, '
'epigallocatechin gallate, nobiletin, resveratrol and curcumin were ORF3a inhibitors, with '
'IC<jats:sub>50</jats:sub> values ranging between 1 and 6\xa0µM, while 6-gingerol, apigenin, '
'naringenin and genistein were inactive. For flavonoids, inhibitory activity could be related '
'to the pattern of OH groups on the chromone ring system. Thus, the ORF3a viroporin of '
'SARS-CoV-2 may indeed be a promising target for antiviral drugs.</jats:p>',
'DOI': '10.1038/s41598-023-31764-9',
'type': 'journal-article',
'created': {'date-parts': [[2023, 4, 3]], 'date-time': '2023-04-03T05:50:55Z', 'timestamp': 1680501055000},
'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant '
'metabolites',
'prefix': '10.1038',
'volume': '13',
'author': [ {'given': 'Marina Sherif', 'family': 'Fam', 'sequence': 'first', 'affiliation': []},
{'given': 'Christine Adel', 'family': 'Sedky', 'sequence': 'additional', 'affiliation': []},
{'given': 'Nancy Osama', 'family': 'Turky', 'sequence': 'additional', 'affiliation': []},
{'given': 'Hans-Georg', 'family': 'Breitinger', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ulrike', 'family': 'Breitinger', 'sequence': 'additional', 'affiliation': []}],
'member': '297',
'published-online': {'date-parts': [[2023, 4, 1]]},
'reference': [ { 'issue': '4',
'key': '31764_CR1',
'doi-asserted-by': 'publisher',
'first-page': '536',
'DOI': '10.1038/s41564-020-0695-z',
'volume': '5',
'author': 'AE Gorbalenya',
'year': '2020',
'unstructured': 'Gorbalenya, A. E. et al. The species Severe acute respiratory '
'syndrome-related coronavirus: classifying 2019-nCoV and naming it '
'SARS-CoV-2. Nat. Microbiol. 5(4), 536–544. '
'https://doi.org/10.1038/s41564-020-0695-z (2020).',
'journal-title': 'Nat. Microbiol.'},
{ 'key': '31764_CR2',
'doi-asserted-by': 'publisher',
'first-page': '1',
'DOI': '10.1007/978-1-0716-0900-2_1',
'volume-title': 'Coronaviruses: Methods and Protocols',
'author': 'Y Wang',
'year': '2020',
'unstructured': 'Wang, Y., Grunewald, M. & Perlman, S. coronaviruses: an updated overview '
'of their replication and pathogenesis. In Coronaviruses: Methods and '
'Protocols (eds Maier, H. J. & Bickerton, E.) 1–29 (Springer US, 2020). '
'https://doi.org/10.1007/978-1-0716-0900-2_1.'},
{ 'key': '31764_CR3',
'doi-asserted-by': 'publisher',
'first-page': '523',
'DOI': '10.1038/nrmicro.2016.81',
'volume': '14',
'author': 'E de Wit',
'year': '2016',
'unstructured': 'de Wit, E., van Doremalen, N., Falzarano, D. & Munster, V. J. SARS and '
'MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. '
'14, 523–534. https://doi.org/10.1038/nrmicro.2016.81 (2016).',
'journal-title': 'Nat. Rev. Microbiol.'},
{ 'key': '31764_CR4',
'doi-asserted-by': 'publisher',
'first-page': '26',
'DOI': '10.3390/diseases4030026',
'volume': '4',
'author': 'YX Lim',
'year': '2016',
'unstructured': 'Lim, Y. X., Ng, Y. L., Tam, J. P. & Liu, D. X. Human coronaviruses: a '
'review of virus-host interactions. Diseases 4, 26 (2016).',
'journal-title': 'Diseases'},
{ 'key': '31764_CR5',
'doi-asserted-by': 'publisher',
'first-page': '281',
'DOI': '10.1007/s12098-020-03263-6',
'volume': '87',
'author': 'T Singhal',
'year': '2020',
'unstructured': 'Singhal, T. A review of coronavirus disease-2019 (COVID-19). Indian J. '
'Pediatr. 87, 281–286. https://doi.org/10.1007/s12098-020-03263-6 (2020).',
'journal-title': 'Indian J. Pediatr.'},
{ 'key': '31764_CR6',
'doi-asserted-by': 'publisher',
'first-page': '1015',
'DOI': '10.1097/CM9.0000000000000722',
'volume': '133',
'author': 'LL Ren',
'year': '2020',
'unstructured': 'Ren, L. L. et al. Identification of a novel coronavirus causing severe '
'pneumonia in human: a descriptive study. Chin. Med. J. (Engl.) 133, '
'1015–1024. https://doi.org/10.1097/CM9.0000000000000722 (2020).',
'journal-title': 'Chin. Med. J. (Engl.)'},
{ 'key': '31764_CR7',
'doi-asserted-by': 'publisher',
'first-page': '1',
'DOI': '10.1016/j.ijsu.2020.07.032',
'volume': '81',
'author': 'J Liu',
'year': '2020',
'unstructured': 'Liu, J. et al. A comparative overview of COVID-19, MERS and SARS: review '
'article. Int. J. Surg. 81, 1–8. '
'https://doi.org/10.1016/j.ijsu.2020.07.032 (2020).',
'journal-title': 'Int. J. Surg.'},
{ 'key': '31764_CR8',
'doi-asserted-by': 'publisher',
'first-page': '165878',
'DOI': '10.1016/j.bbadis.2020.165878',
'volume': '1866',
'author': 'AAT Naqvi',
'year': '2020',
'unstructured': 'Naqvi, A. A. T. et al. Insights into SARS-CoV-2 genome, structure, '
'evolution, pathogenesis and therapies: structural genomics approach. '
'Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165878. '
'https://doi.org/10.1016/j.bbadis.2020.165878 (2020).',
'journal-title': 'Biochim. Biophys. Acta Mol. Basis Dis.'},
{ 'key': '31764_CR9',
'doi-asserted-by': 'publisher',
'first-page': '708264',
'DOI': '10.3389/fimmu.2021.708264',
'volume': '12',
'author': 'N Redondo',
'year': '2021',
'unstructured': 'Redondo, N., Zaldívar-López, S., Garrido, J. J. & Montoya, M. SARS-CoV-2 '
'accessory proteins in viral pathogenesis: knowns and unknowns. Front. '
'Immunol. 12, 708264 (2021).',
'journal-title': 'Front. Immunol.'},
{ 'key': '31764_CR10',
'doi-asserted-by': 'publisher',
'first-page': '1399',
'DOI': '10.1126/science.1085953',
'volume': '300',
'author': 'MA Marra',
'year': '2003',
'unstructured': 'Marra, M. A. et al. The Genome sequence of the SARS-associated '
'coronavirus. Science 300, 1399–1404. '
'https://doi.org/10.1126/science.1085953 (2003).',
'journal-title': 'Science'},
{ 'key': '31764_CR11',
'doi-asserted-by': 'publisher',
'first-page': '1270',
'DOI': '10.3390/v13071270',
'volume': '13',
'author': 'Y Vakulenko',
'year': '2021',
'unstructured': 'Vakulenko, Y., Deviatkin, A., Drexler, J. F. & Lukashev, A. Modular '
'evolution of coronavirus genomes. Viruses 13, 1270 (2021).',
'journal-title': 'Viruses'},
{ 'key': '31764_CR12',
'doi-asserted-by': 'publisher',
'first-page': '106185',
'DOI': '10.1016/j.biocel.2022.106185',
'volume': '145',
'author': 'U Breitinger',
'year': '2022',
'unstructured': 'Breitinger, U., Farag, N. S., Sticht, H. & Breitinger, H. G. Viroporins: '
'Structure, function, and their role in the life cycle of SARS-CoV-2. '
'Int. J. Biochem. Cell Biol. 145, 106185. '
'https://doi.org/10.1016/j.biocel.2022.106185 (2022).',
'journal-title': 'Int. J. Biochem. Cell Biol.'},
{ 'key': '31764_CR13',
'doi-asserted-by': 'publisher',
'first-page': '28',
'DOI': '10.1016/S0014-5793(03)00780-4',
'volume': '552',
'author': 'ME Gonzalez',
'year': '2003',
'unstructured': 'Gonzalez, M. E. & Carrasco, L. Viroporins. FEBS Lett. 552, 28–34 (2003).',
'journal-title': 'FEBS Lett.'},
{ 'key': '31764_CR14',
'doi-asserted-by': 'publisher',
'first-page': '563',
'DOI': '10.1038/nrmicro2820',
'volume': '10',
'author': 'JL Nieva',
'year': '2012',
'unstructured': 'Nieva, J. L., Madan, V. & Carrasco, L. Viroporins: structure and '
'biological functions. Nat. Rev. Microbiol. 10, 563–574. '
'https://doi.org/10.1038/nrmicro2820 (2012).',
'journal-title': 'Nat. Rev. Microbiol.'},
{ 'key': '31764_CR15',
'doi-asserted-by': 'publisher',
'first-page': '2000',
'DOI': '10.1099/vir.0.000201',
'volume': '96',
'author': 'C Scott',
'year': '2015',
'unstructured': 'Scott, C. & Griffin, S. Viroporins: structure, function and potential as '
'antiviral targets. J. Gen. Virol. 96, 2000–2027. '
'https://doi.org/10.1099/vir.0.000201 (2015).',
'journal-title': 'J. Gen. Virol.'},
{ 'key': '31764_CR16',
'doi-asserted-by': 'publisher',
'first-page': '365',
'DOI': '10.1007/s11262-009-0341-6',
'volume': '38',
'author': 'SC Chen',
'year': '2009',
'unstructured': 'Chen, S. C., Lo, S. Y., Ma, H. C. & Li, H. C. Expression and membrane '
'integration of SARS-CoV E protein and its interaction with M protein. '
'Virus Genes 38, 365–371. https://doi.org/10.1007/s11262-009-0341-6 '
'(2009).',
'journal-title': 'Virus Genes'},
{ 'key': '31764_CR17',
'doi-asserted-by': 'publisher',
'first-page': 'e1004320',
'DOI': '10.1371/journal.ppat.1004320',
'volume': '10',
'author': 'JM Jimenez-Guardeno',
'year': '2014',
'unstructured': 'Jimenez-Guardeno, J. M. et al. The PDZ-binding motif of severe acute '
'respiratory syndrome coronavirus envelope protein is a determinant of '
'viral pathogenesis. PLoS Pathog. 10, e1004320. '
'https://doi.org/10.1371/journal.ppat.1004320 (2014).',
'journal-title': 'PLoS Pathog.'},
{ 'key': '31764_CR18',
'doi-asserted-by': 'publisher',
'first-page': '199',
'DOI': '10.1007/978-0-387-33012-9_34',
'volume': '581',
'author': 'Y Liao',
'year': '2006',
'unstructured': 'Liao, Y., Tam, J. P. & Liu, D. X. Viroporin activity of SARS-CoV E '
'protein. Adv. Exp. Med. Biol. 581, 199–202. '
'https://doi.org/10.1007/978-0-387-33012-9_34 (2006).',
'journal-title': 'Adv. Exp. Med. Biol.'},
{ 'key': '31764_CR19',
'doi-asserted-by': 'publisher',
'first-page': '3870',
'DOI': '10.1128/JVI.03566-14',
'volume': '89',
'author': 'JA Regla-Nava',
'year': '2015',
'unstructured': 'Regla-Nava, J. A. et al. Severe acute respiratory syndrome coronaviruses '
'with mutations in the E protein are attenuated and promising vaccine '
'candidates. J. Virol. 89, 3870–3887. '
'https://doi.org/10.1128/JVI.03566-14 (2015).',
'journal-title': 'J. Virol.'},
{ 'key': '31764_CR20',
'doi-asserted-by': 'publisher',
'first-page': '363',
'DOI': '10.3390/v4030363',
'volume': '4',
'author': 'TR Ruch',
'year': '2012',
'unstructured': 'Ruch, T. R. & Machamer, C. E. The coronavirus E protein: assembly and '
'beyond. Viruses 4, 363–382. https://doi.org/10.3390/v4030363 (2012).',
'journal-title': 'Viruses'},
{ 'key': '31764_CR21',
'doi-asserted-by': 'publisher',
'first-page': '3838',
'DOI': '10.1091/mbc.E10-04-0338',
'volume': '21',
'author': 'KT Teoh',
'year': '2010',
'unstructured': 'Teoh, K. T. et al. The SARS coronavirus E protein interacts with PALS1 '
'and alters tight junction formation and epithelial morphogenesis. Mol. '
'Biol. Cell 21, 3838–3852. https://doi.org/10.1091/mbc.E10-04-0338 '
'(2010).',
'journal-title': 'Mol. Biol. Cell'},
{ 'key': '31764_CR22',
'doi-asserted-by': 'publisher',
'first-page': '485',
'DOI': '10.1016/j.virol.2012.07.005',
'volume': '432',
'author': 'C Verdia-Baguena',
'year': '2012',
'unstructured': 'Verdia-Baguena, C. et al. Coronavirus E protein forms ion channels with '
'functionally and structurally-involved membrane lipids. Virology 432, '
'485–494. https://doi.org/10.1016/j.virol.2012.07.005 (2012).',
'journal-title': 'Virology'},
{ 'key': '31764_CR23',
'doi-asserted-by': 'publisher',
'first-page': '294',
'DOI': '10.1016/j.virol.2006.05.028',
'volume': '353',
'author': 'L Wilson',
'year': '2006',
'unstructured': 'Wilson, L., Gage, P. & Ewart, G. Hexamethylene amiloride blocks E '
'protein ion channels and inhibits coronavirus replication. Virology 353, '
'294–306. https://doi.org/10.1016/j.virol.2006.05.028 (2006).',
'journal-title': 'Virology'},
{ 'key': '31764_CR24',
'doi-asserted-by': 'publisher',
'first-page': '459',
'DOI': '10.1038/s41586-020-2286-9',
'volume': '583',
'author': 'DE Gordon',
'year': '2020',
'unstructured': 'Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals '
'targets for drug repurposing. Nature 583, 459–468. '
'https://doi.org/10.1038/s41586-020-2286-9 (2020).',
'journal-title': 'Nature'},
{ 'key': '31764_CR25',
'doi-asserted-by': 'publisher',
'first-page': '131',
'DOI': '10.1186/s12985-020-01402-1',
'volume': '17',
'author': 'CJ Michel',
'year': '2020',
'unstructured': 'Michel, C. J., Mayer, C., Poch, O. & Thompson, J. D. Characterization of '
'accessory genes in coronavirus genomes. Virol. J. 17, 131. '
'https://doi.org/10.1186/s12985-020-01402-1 (2020).',
'journal-title': 'Virol. J.'},
{ 'key': '31764_CR26',
'doi-asserted-by': 'publisher',
'first-page': '854567',
'DOI': '10.3389/fmicb.2022.854567',
'volume': '13',
'author': 'J Zhang',
'year': '2022',
'unstructured': 'Zhang, J. et al. Understanding the role of SARS-CoV-2 ORF3a in viral '
'pathogenesis and COVID-19. Front Microbiol 13, 854567. '
'https://doi.org/10.3389/fmicb.2022.854567 (2022).',
'journal-title': 'Front Microbiol'},
{ 'key': '31764_CR27',
'doi-asserted-by': 'publisher',
'author': 'C Castano-Rodriguez',
'year': '2018',
'unstructured': 'Castano-Rodriguez, C. et al. Role of severe acute respiratory syndrome '
'coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. '
'mBio https://doi.org/10.1128/mBio.02325-17 (2018).',
'journal-title': 'mBio',
'DOI': '10.1128/mBio.02325-17'},
{ 'key': '31764_CR28',
'first-page': '439',
'volume': '9',
'author': 'DM Kern',
'year': '2021',
'unstructured': 'Kern, D. M. et al. Cryo-EM structure of the SARS-CoV-2 3a ion channel in '
'lipid nanodiscs. bioRxiv 9, 439 (2021).',
'journal-title': 'bioRxiv'},
{ 'key': '31764_CR29',
'doi-asserted-by': 'publisher',
'first-page': '2232',
'DOI': '10.1016/j.biocel.2009.04.019',
'volume': '41',
'author': 'CM Chan',
'year': '2009',
'unstructured': 'Chan, C. M. et al. The ion channel activity of the SARS-coronavirus 3a '
'protein is linked to its pro-apoptotic function. Int. J. Biochem. Cell '
'Biol. 41, 2232–2239. https://doi.org/10.1016/j.biocel.2009.04.019 '
'(2009).',
'journal-title': 'Int. J. Biochem. Cell Biol.'},
{ 'key': '31764_CR30',
'doi-asserted-by': 'publisher',
'first-page': '50',
'DOI': '10.3389/fmicb.2019.00050',
'volume': '10',
'author': 'IY Chen',
'year': '2019',
'unstructured': 'Chen, I. Y., Moriyama, M., Chang, M. F. & Ichinohe, T. Severe acute '
'respiratory syndrome coronavirus viroporin 3a activates the NLRP3 '
'inflammasome. Front. Microbiol. 10, 50. '
'https://doi.org/10.3389/fmicb.2019.00050 (2019).',
'journal-title': 'Front. Microbiol.'},
{ 'key': '31764_CR31',
'doi-asserted-by': 'publisher',
'first-page': '1921',
'DOI': '10.1099/vir.0.80813-0',
'volume': '86',
'author': 'PTW Law',
'year': '2005',
'unstructured': 'Law, P. T. W. et al. The 3a protein of severe acute respiratory '
'syndrome-associated coronavirus induces apoptosis in Vero E6 cells. J. '
'Gen. Virol. 86, 1921–1930. https://doi.org/10.1099/vir.0.80813-0 (2005).',
'journal-title': 'J. Gen. Virol.'},
{ 'key': '31764_CR32',
'doi-asserted-by': 'publisher',
'first-page': '6807',
'DOI': '10.1016/j.febslet.2006.11.046',
'volume': '580',
'author': 'N Kanzawa',
'year': '2006',
'unstructured': 'Kanzawa, N. et al. Augmentation of chemokine production by severe acute '
'respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through '
'NF-kappaB activation. FEBS Lett. 580, 6807–6812. '
'https://doi.org/10.1016/j.febslet.2006.11.046 (2006).',
'journal-title': 'FEBS Lett.'},
{ 'key': '31764_CR33',
'doi-asserted-by': 'publisher',
'first-page': '1960',
'DOI': '10.1099/vir.0.83665-0',
'volume': '89',
'author': 'K Padhan',
'year': '2008',
'unstructured': 'Padhan, K., Minakshi, R., Towheed, M. A. B. & Jameel, S. Severe acute '
'respiratory syndrome coronavirus 3a protein activates the mitochondrial '
'death pathway through p38 MAP kinase activation. J. Gen. Virol. 89, '
'1960–1969. https://doi.org/10.1099/vir.0.83665-0 (2008).',
'journal-title': 'J. Gen. Virol.'},
{ 'key': '31764_CR34',
'doi-asserted-by': 'publisher',
'first-page': '1097',
'DOI': '10.1128/JVI.01662-09',
'volume': '84',
'author': 'EC Freundt',
'year': '2010',
'unstructured': 'Freundt, E. C. et al. The open reading frame 3a protein of severe acute '
'respiratory syndrome-associated coronavirus promotes membrane '
'rearrangement and cell death. J. Virol. 84, 1097–1109. '
'https://doi.org/10.1128/JVI.01662-09 (2010).',
'journal-title': 'J. Virol.'},
{ 'key': '31764_CR35',
'unstructured': 'Kien, F., Ma, H., Gaisenband, S. D. & Nal, B. in Microbial Pathogenesis: '
'Infection and Immunity (ed Uday Kishore and Annapurna Nayak) Ch. 3, '
'38–62 (Landes Bioscience and Springer Science+Business Media, 2013).'},
{ 'key': '31764_CR36',
'doi-asserted-by': 'publisher',
'first-page': '177',
'DOI': '10.1055/s-0033-1360277',
'volume': '80',
'author': 'S Schwarz',
'year': '2014',
'unstructured': 'Schwarz, S. et al. Kaempferol derivatives as antiviral drugs against the '
'3a channel protein of coronavirus. Planta Med. 80, 177–182. '
'https://doi.org/10.1055/s-0033-1360277 (2014).',
'journal-title': 'Planta Med.'},
{ 'key': '31764_CR37',
'doi-asserted-by': 'publisher',
'first-page': '64',
'DOI': '10.1016/j.antiviral.2011.02.008',
'volume': '90',
'author': 'S Schwarz',
'year': '2011',
'unstructured': 'Schwarz, S., Wang, K., Yu, W., Sun, B. & Schwarz, W. Emodin inhibits '
'current through SARS-associated coronavirus 3a protein. Antiviral Res. '
'90, 64–69. https://doi.org/10.1016/j.antiviral.2011.02.008 (2011).',
'journal-title': 'Antiviral Res.'},
{ 'key': '31764_CR38',
'doi-asserted-by': 'publisher',
'first-page': '427',
'DOI': '10.1016/j.devcel.2020.12.010',
'volume': '56',
'author': 'G Miao',
'year': '2021',
'unstructured': 'Miao, G. et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS '
'complex-mediated assembly of the SNARE complex required for autolysosome '
'formation. Dev. Cell 56, 427–442. '
'https://doi.org/10.1016/j.devcel.2020.12.010 (2021).',
'journal-title': 'Dev. Cell'},
{ 'key': '31764_CR39',
'doi-asserted-by': 'publisher',
'first-page': '716208',
'DOI': '10.3389/fcell.2021.716208',
'volume': '9',
'author': 'Y Qu',
'year': '2021',
'unstructured': 'Qu, Y. et al. ORF3a-mediated incomplete autophagy facilitates severe '
'acute respiratory syndrome coronavirus-2 replication. Front. Cell Dev. '
'Biol. 9, 716208. https://doi.org/10.3389/fcell.2021.716208 (2021).',
'journal-title': 'Front. Cell Dev. Biol.'},
{ 'key': '31764_CR40',
'doi-asserted-by': 'publisher',
'first-page': '31',
'DOI': '10.1038/s41421-021-00268-z',
'volume': '7',
'author': 'Y Zhang',
'year': '2021',
'unstructured': 'Zhang, Y. et al. The SARS-CoV-2 protein ORF3a inhibits fusion of '
'autophagosomes with lysosomes. Cell Discov. 7, 31. '
'https://doi.org/10.1038/s41421-021-00268-z (2021).',
'journal-title': 'Cell Discov.'},
{ 'key': '31764_CR41',
'doi-asserted-by': 'publisher',
'first-page': '2467',
'DOI': '10.3390/v13122467',
'volume': '13',
'author': 'WQ Su',
'year': '2021',
'unstructured': 'Su, W. Q., Yu, X. J. & Zhou, C. M. SARS-CoV-2 ORF3a induces incomplete '
'autophagy via the unfolded protein response. Viruses 13, 2467 (2021).',
'journal-title': 'Viruses'},
{ 'key': '31764_CR42',
'doi-asserted-by': 'publisher',
'first-page': '13',
'DOI': '10.1016/j.virol.2022.01.003',
'volume': '568',
'author': 'H Xu',
'year': '2022',
'unstructured': 'Xu, H. et al. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 '
'inflammatory pathway. Virology 568, 13–22. '
'https://doi.org/10.1016/j.virol.2022.01.003 (2022).',
'journal-title': 'Virology'},
{ 'key': '31764_CR43',
'doi-asserted-by': 'publisher',
'first-page': '881',
'DOI': '10.1038/s41423-020-0485-9',
'volume': '17',
'author': 'Y Ren',
'year': '2020',
'unstructured': 'Ren, Y. et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in '
'cells. Cell Mol. Immunol. 17, 881–883. '
'https://doi.org/10.1038/s41423-020-0485-9 (2020).',
'journal-title': 'Cell Mol. Immunol.'},
{ 'key': '31764_CR44',
'first-page': '8',
'volume': '204',
'author': 'N Arshad',
'year': '2022',
'unstructured': 'Arshad, N. et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use '
'distinct mechanisms to downregulate MHC-I surface expression. bioRxiv '
'204, 8 (2022).',
'journal-title': 'bioRxiv'},
{ 'key': '31764_CR45',
'doi-asserted-by': 'publisher',
'first-page': '766',
'DOI': '10.1016/j.csbj.2022.01.017',
'volume': '20',
'author': 'S Gupta',
'year': '2022',
'unstructured': 'Gupta, S. et al. D155Y substitution of SARS-CoV-2 ORF3a weakens binding '
'with Caveolin-1. Comput. Struct. Biotechnol. J. 20, 766–778. '
'https://doi.org/10.1016/j.csbj.2022.01.017 (2022).',
'journal-title': 'Comput. Struct. Biotechnol. J.'},
{ 'key': '31764_CR46',
'doi-asserted-by': 'publisher',
'first-page': '3067',
'DOI': '10.1099/vir.0.82856-0',
'volume': '88',
'author': 'K Padhan',
'year': '2007',
'unstructured': 'Padhan, K. et al. Severe acute respiratory syndrome coronavirus ORF3a '
'protein interacts with caveolin. J. Gen. Virol. 88, 3067–3077. '
'https://doi.org/10.1099/vir.0.82856-0 (2007).',
'journal-title': 'J. Gen. Virol.'},
{ 'key': '31764_CR47',
'doi-asserted-by': 'publisher',
'first-page': '904',
'DOI': '10.1038/s41419-018-0917-y',
'volume': '9',
'author': 'Y Yue',
'year': '2018',
'unstructured': 'Yue, Y. et al. SARS-coronavirus open reading frame-3a drives multimodal '
'necrotic cell death. Cell Death Dis. 9, 904. '
'https://doi.org/10.1038/s41419-018-0917-y (2018).',
'journal-title': 'Cell Death Dis.'},
{ 'key': '31764_CR48',
'doi-asserted-by': 'publisher',
'first-page': '100933',
'DOI': '10.1016/j.bbrep.2021.100933',
'volume': '26',
'author': 'GK Azad',
'year': '2021',
'unstructured': 'Azad, G. K. & Khan, P. K. Variations in ORF3a protein of SARS-CoV-2 '
'alter its structure and function. Biochem. Biophys. Rep. 26, 100933. '
'https://doi.org/10.1016/j.bbrep.2021.100933 (2021).',
'journal-title': 'Biochem. Biophys. Rep.'},
{ 'key': '31764_CR49',
'doi-asserted-by': 'publisher',
'first-page': '820',
'DOI': '10.1016/j.ijbiomac.2020.12.142',
'volume': '170',
'author': 'M Bianchi',
'year': '2021',
'unstructured': 'Bianchi, M., Borsetti, A., Ciccozzi, M. & Pascarella, S. SARS-CoV-2 '
'ORF3a: mutability and function. Int. J. Biol. Macromol. 170, 820–826. '
'https://doi.org/10.1016/j.ijbiomac.2020.12.142 (2021).',
'journal-title': 'Int. J. Biol. Macromol.'},
{ 'key': '31764_CR50',
'doi-asserted-by': 'publisher',
'first-page': '198441',
'DOI': '10.1016/j.virusres.2021.198441',
'volume': '300',
'author': 'SS Hassan',
'year': '2021',
'unstructured': 'Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P. & Roy, B. '
'Pathogenic perspective of missense mutations of ORF3a protein of '
'SARS-CoV-2. Virus Res. 300, 198441. '
'https://doi.org/10.1016/j.virusres.2021.198441 (2021).',
'journal-title': 'Virus Res.'},
{ 'key': '31764_CR51',
'doi-asserted-by': 'publisher',
'author': 'E Issa',
'year': '2020',
'unstructured': 'Issa, E., Merhi, G., Panossian, B., Salloum, T. & Tokajian, S. '
'SARS-CoV-2 and ORF3a: nonsynonymous mutations, functional domains, and '
'viral pathogenesis. Msystems https://doi.org/10.1128/mSystems.00266-20 '
'(2020).',
'journal-title': 'Msystems',
'DOI': '10.1128/mSystems.00266-20'},
{ 'key': '31764_CR52',
'doi-asserted-by': 'publisher',
'first-page': 'e262',
'DOI': '10.1017/S0950268820002599',
'volume': '148',
'author': 'P Majumdar',
'year': '2020',
'unstructured': 'Majumdar, P. & Niyogi, S. ORF3a mutation associated with higher '
'mortality rate in SARS-CoV-2 infection. Epidemiol. Infect. 148, e262. '
'https://doi.org/10.1017/S0950268820002599 (2020).',
'journal-title': 'Epidemiol. Infect.'},
{ 'key': '31764_CR53',
'doi-asserted-by': 'publisher',
'first-page': '2082',
'DOI': '10.3390/v13102082',
'volume': '13',
'author': 'Y Zhou',
'year': '2021',
'unstructured': 'Zhou, Y. et al. Efficacy of ion-channel inhibitors amantadine, memantine '
'and rimantadine for the treatment of SARS-CoV-2 in vitro. Viruses 13, '
'2082. https://doi.org/10.3390/v13102082 (2021).',
'journal-title': 'Viruses'},
{ 'key': '31764_CR54',
'doi-asserted-by': 'publisher',
'first-page': '19481',
'DOI': '10.1038/s41598-021-99072-8',
'volume': '11',
'author': 'NS Lebedeva',
'year': '2021',
'unstructured': 'Lebedeva, N. S. et al. Theoretical and experimental study of interaction '
'of macroheterocyclic compounds with ORF3a of SARS-CoV-2. Sci. Rep. 11, '
'19481. https://doi.org/10.1038/s41598-021-99072-8 (2021).',
'journal-title': 'Sci. Rep.'},
{ 'key': '31764_CR55',
'doi-asserted-by': 'publisher',
'first-page': 'e0007548',
'DOI': '10.1371/journal.pntd.0007548',
'volume': '13',
'author': 'D Dey',
'year': '2019',
'unstructured': 'Dey, D. et al. The effect of amantadine on an ion channel protein from '
'Chikungunya virus. PLoS Negl. Trop. Dis. 13, e0007548. '
'https://doi.org/10.1371/journal.pntd.0007548 (2019).',
'journal-title': 'PLoS Negl. Trop. Dis.'},
{ 'key': '31764_CR56',
'doi-asserted-by': 'publisher',
'first-page': '485',
'DOI': '10.1016/0042-6822(92)91239-q',
'volume': '190',
'author': 'KC Duff',
'year': '1992',
'unstructured': 'Duff, K. C. & Ashley, R. H. The transmembrane domain of influenza A M2 '
'protein forms amantadine-sensitive proton channels in planar lipid '
'bilayers. Virology 190, 485–489. '
'https://doi.org/10.1016/0042-6822(92)91239-q (1992).',
'journal-title': 'Virology'},
{ 'key': '31764_CR57',
'first-page': '189',
'volume': '55',
'author': 'DM Fleming',
'year': '2001',
'unstructured': 'Fleming, D. M. Managing influenza: amantadine, rimantadine and beyond. '
'Int. J. Clin. Pract. 55, 189–195 (2001).',
'journal-title': 'Int. J. Clin. Pract.'},
{ 'key': '31764_CR58',
'doi-asserted-by': 'publisher',
'first-page': '34',
'DOI': '10.1016/S0014-5793(02)03851-6',
'volume': '535',
'author': 'SD Griffin',
'year': '2003',
'unstructured': 'Griffin, S. D. et al. The p7 protein of hepatitis C virus forms an ion '
'channel that is blocked by the antiviral drug Amantadine. FEBS Lett. '
'535, 34–38 (2003).',
'journal-title': 'FEBS Lett.'},
{ 'key': '31764_CR59',
'doi-asserted-by': 'publisher',
'first-page': '342',
'DOI': '10.1016/j.jmgm.2008.06.002',
'volume': '27',
'author': 'P Intharathep',
'year': '2008',
'unstructured': 'Intharathep, P. et al. How amantadine and rimantadine inhibit proton '
'transport in the M2 protein channel. J. Mol. Graph Model. 27, 342–348. '
'https://doi.org/10.1016/j.jmgm.2008.06.002 (2008).',
'journal-title': 'J. Mol. Graph Model.'},
{ 'key': '31764_CR60',
'doi-asserted-by': 'publisher',
'first-page': '10967',
'DOI': '10.1073/pnas.0804958105',
'volume': '105',
'author': 'X Jing',
'year': '2008',
'unstructured': 'Jing, X. et al. Functional studies indicate amantadine binds to the pore '
'of the influenza A virus M2 proton-selective ion channel. Proc. Natl. '
'Acad. Sci. U. S. A. 105, 10967–10972. '
'https://doi.org/10.1073/pnas.0804958105 (2008).',
'journal-title': 'Proc. Natl. Acad. Sci. U. S. A.'},
{ 'key': '31764_CR61',
'doi-asserted-by': 'publisher',
'first-page': '2065',
'DOI': '10.1110/ps.062730007',
'volume': '16',
'author': 'J Torres',
'year': '2007',
'unstructured': 'Torres, J. et al. Conductance and amantadine binding of a pore formed by '
'a lysine-flanked transmembrane domain of SARS coronavirus envelope '
'protein. Protein Sci. 16, 2065–2071. '
'https://doi.org/10.1110/ps.062730007 (2007).',
'journal-title': 'Protein Sci.'},
{ 'key': '31764_CR62',
'doi-asserted-by': 'publisher',
'first-page': '63',
'DOI': '10.3390/molecules25010063',
'volume': '25',
'author': 'E Cione',
'year': '2019',
'unstructured': 'Cione, E. et al. Quercetin, epigallocatechin gallate, curcumin, and '
'resveratrol: from dietary sources to human MicroRNA modulation. '
'Molecules 25, 63. https://doi.org/10.3390/molecules25010063 (2019).',
'journal-title': 'Molecules'},
{ 'key': '31764_CR63',
'doi-asserted-by': 'publisher',
'first-page': 'e47',
'DOI': '10.1017/jns.2016.41',
'volume': '5',
'author': 'AN Panche',
'year': '2016',
'unstructured': 'Panche, A. N., Diwan, A. D. & Chandra, S. R. Flavonoids: an overview. J. '
'Nutr. Sci. 5, e47 (2016).',
'journal-title': 'J. Nutr. Sci.'},
{ 'key': '31764_CR64',
'doi-asserted-by': 'publisher',
'first-page': '12385',
'DOI': '10.3390/ijms222212385',
'volume': '22',
'author': 'N Gligorijevic',
'year': '2021',
'unstructured': 'Gligorijevic, N. et al. Molecular mechanisms of possible action of '
'phenolic compounds in COVID-19 protection and prevention. Int. J. Mol. '
'Sci. 22, 12385 (2021).',
'journal-title': 'Int. J. Mol. Sci.'},
{ 'key': '31764_CR65',
'doi-asserted-by': 'publisher',
'first-page': '93',
'DOI': '10.3390/medicines5030093',
'volume': '5',
'author': 'D Tungmunnithum',
'year': '2018',
'unstructured': 'Tungmunnithum, D., Thongboonyou, A., Pholboon, A. & Yangsabai, A. '
'Flavonoids and other phenolic compounds from medicinal plants for '
'pharmaceutical and medical aspects: an overview. Medicines (Basel) 5, 93 '
'(2018).',
'journal-title': 'Medicines (Basel)'},
{ 'key': '31764_CR66',
'doi-asserted-by': 'publisher',
'first-page': '184241',
'DOI': '10.1155/2015/184241',
'volume': '2015',
'author': 'Y Abba',
'year': '2015',
'unstructured': 'Abba, Y., Hassim, H., Hamzah, H. & Noordin, M. M. Antiviral activity of '
'resveratrol against human and animal viruses. Adv. Virol. 2015, 184241 '
'(2015).',
'journal-title': 'Adv. Virol.'},
{ 'key': '31764_CR67',
'doi-asserted-by': 'publisher',
'first-page': '50',
'DOI': '10.1042/BST0380050',
'volume': '38',
'author': 'M Campagna',
'year': '2010',
'unstructured': 'Campagna, M. & Rivas, C. Antiviral activity of resveratrol. Biochem. '
'Soc. Trans. 38, 50–53. https://doi.org/10.1042/BST0380050 (2010).',
'journal-title': 'Biochem. Soc. Trans.'},
{ 'key': '31764_CR68',
'doi-asserted-by': 'publisher',
'first-page': '7138756',
'DOI': '10.1155/2022/7138756',
'volume': '2022',
'author': 'X Chen',
'year': '2022',
'unstructured': 'Chen, X. et al. Insights into the anti-inflammatory and antiviral '
'mechanisms of resveratrol. Mediat. Inflamm. 2022, 7138756. '
'https://doi.org/10.1155/2022/7138756 (2022).',
'journal-title': 'Mediat. Inflamm.'},
{ 'key': '31764_CR69',
'doi-asserted-by': 'publisher',
'first-page': '393',
'DOI': '10.1179/joc.2008.20.3.393',
'volume': '20',
'author': 'L Drago',
'year': '2008',
'unstructured': 'Drago, L., Nicola, L., Ossola, F. & De Vecchi, E. In vitro antiviral '
'activity of resveratrol against respiratory viruses. J. Chemother. 20, '
'393–394. https://doi.org/10.1179/joc.2008.20.3.393 (2008).',
'journal-title': 'J. Chemother.'},
{ 'key': '31764_CR70',
'doi-asserted-by': 'publisher',
'first-page': '1242',
'DOI': '10.3390/v12111242',
'volume': '12',
'author': 'MR Jennings',
'year': '2020',
'unstructured': 'Jennings, M. R. & Parks, R. J. Curcumin as an antiviral agent. Viruses '
'12, 1242 (2020).',
'journal-title': 'Viruses'},
{ 'key': '31764_CR71',
'doi-asserted-by': 'publisher',
'first-page': '186864',
'DOI': '10.1155/2014/186864',
'volume': '2014',
'author': 'SZ Moghadamtousi',
'year': '2014',
'unstructured': 'Moghadamtousi, S. Z. et al. A review on antibacterial, antiviral, and '
'antifungal activity of curcumin. Biomed. Res. Int. 2014, 186864. '
'https://doi.org/10.1155/2014/186864 (2014).',
'journal-title': 'Biomed. Res. Int.'},
{ 'key': '31764_CR72',
'doi-asserted-by': 'publisher',
'first-page': '1035',
'DOI': '10.1136/gutjnl-2013-305646',
'volume': '63',
'author': 'EI Pecheur',
'year': '2014',
'unstructured': 'Pecheur, E. I. Curcumin against hepatitis C virus infection: Spicing up '
'antiviral therapies with ‘nutraceuticals’?. Gut 63, 1035–1037. '
'https://doi.org/10.1136/gutjnl-2013-305646 (2014).',
'journal-title': 'Gut'},
{ 'key': '31764_CR73',
'doi-asserted-by': 'publisher',
'first-page': 'e06350',
'DOI': '10.1016/j.heliyon.2021.e06350',
'volume': '7',
'author': 'RK Thimmulappa',
'year': '2021',
'unstructured': 'Thimmulappa, R. K. et al. Antiviral and immunomodulatory activity of '
'curcumin: a case for prophylactic therapy for COVID-19. Heliyon 7, '
'e06350. https://doi.org/10.1016/j.heliyon.2021.e06350 (2021).',
'journal-title': 'Heliyon'},
{ 'key': '31764_CR74',
'doi-asserted-by': 'publisher',
'first-page': '6623400',
'DOI': '10.1155/2021/6623400',
'volume': '2021',
'author': 'RF Hayati',
'year': '2021',
'unstructured': 'Hayati, R. F. et al. [6]-Gingerol inhibits chikungunya virus infection '
'by suppressing viral replication. Biomed. Res. Int. 2021, 6623400. '
'https://doi.org/10.1155/2021/6623400 (2021).',
'journal-title': 'Biomed. Res. Int.'},
{ 'key': '31764_CR75',
'doi-asserted-by': 'publisher',
'first-page': '389',
'DOI': '10.1080/07391102.2020.1813630',
'volume': '40',
'author': 'BJ Oso',
'year': '2022',
'unstructured': 'Oso, B. J., Adeoye, A. O. & Olaoye, I. F. Pharmacoinformatics and '
'hypothetical studies on allicin, curcumin, and gingerol as potential '
'candidates against COVID-19-associated proteases. J. Biomol. Struct. '
'Dyn. 40, 389–400. https://doi.org/10.1080/07391102.2020.1813630 (2022).',
'journal-title': 'J. Biomol. Struct. Dyn.'},
{ 'key': '31764_CR76',
'doi-asserted-by': 'publisher',
'first-page': '1001',
'DOI': '10.4315/0362-028X.JFP-15-593',
'volume': '79',
'author': 'HA Aboubakr',
'year': '2016',
'unstructured': 'Aboubakr, H. A. et al. In vitro antiviral activity of clove and ginger '
'aqueous extracts against feline calicivirus, a surrogate for human '
'norovirus. J. Food Prot. 79, 1001–1012. '
'https://doi.org/10.4315/0362-028X.JFP-15-593 (2016).',
'journal-title': 'J. Food Prot.'},
{ 'key': '31764_CR77',
'doi-asserted-by': 'publisher',
'first-page': '146',
'DOI': '10.1016/j.jep.2012.10.043',
'volume': '145',
'author': 'JS Chang',
'year': '2013',
'unstructured': 'Chang, J. S., Wang, K. C., Yeh, C. F., Shieh, D. E. & Chiang, L. C. '
'Fresh ginger (Zingiber officinale) has anti-viral activity against human '
'respiratory syncytial virus in human respiratory tract cell lines. J. '
'Ethnopharmacol. 145, 146–151. https://doi.org/10.1016/j.jep.2012.10.043 '
'(2013).',
'journal-title': 'J. Ethnopharmacol.'},
{ 'key': '31764_CR78',
'doi-asserted-by': 'publisher',
'first-page': '270',
'DOI': '10.1007/s13337-020-00584-0',
'volume': '31',
'author': 'S Kaushik',
'year': '2020',
'unstructured': 'Kaushik, S., Jangra, G., Kundu, V., Yadav, J. P. & Kaushik, S. '
'Anti-viral activity of Zingiber officinale (Ginger) ingredients against '
'the Chikungunya virus. Virusdisease 31, 270–276. '
'https://doi.org/10.1007/s13337-020-00584-0 (2020).',
'journal-title': 'Virusdisease'},
{ 'key': '31764_CR79',
'doi-asserted-by': 'publisher',
'author': 'U Breitinger',
'year': '2021',
'unstructured': 'Breitinger, U. et al. Cell viability assay as a tool to study activity '
'and inhibition of hepatitis C p7 channels. J. Gen. Virol. '
'https://doi.org/10.1099/jgv.0.001571 (2021).',
'journal-title': 'J. Gen. Virol.',
'DOI': '10.1099/jgv.0.001571'},
{ 'key': '31764_CR80',
'doi-asserted-by': 'publisher',
'first-page': '692423',
'DOI': '10.3389/fmicb.2021.692423',
'volume': '12',
'author': 'U Breitinger',
'year': '2021',
'unstructured': 'Breitinger, U., Ali, N. K. M., Sticht, H. & Breitinger, H. G. Inhibition '
'of SARS CoV envelope protein by flavonoids and classical viroporin '
'inhibitors. Front. Microbiol. 12, 692423. '
'https://doi.org/10.3389/fmicb.2021.692423 (2021).',
'journal-title': 'Front. Microbiol.'},
{ 'key': '31764_CR81',
'doi-asserted-by': 'publisher',
'first-page': '14160',
'DOI': '10.1021/bi001799u',
'volume': '39',
'author': 'D Salom',
'year': '2000',
'unstructured': 'Salom, D., Hill, B. R., Lear, J. D. & DeGrado, W. F. pH-dependent '
'tetramerization and amantadine binding of the transmembrane helix of M2 '
'from the influenza A virus. Biochemistry 39, 14160–14170. '
'https://doi.org/10.1021/bi001799u (2000).',
'journal-title': 'Biochemistry'},
{ 'key': '31764_CR82',
'doi-asserted-by': 'publisher',
'first-page': '2419',
'DOI': '10.1016/j.bpj.2016.04.018',
'volume': '110',
'author': 'U Breitinger',
'year': '2016',
'unstructured': 'Breitinger, U., Farag, N. S., Ali, N. K. & Breitinger, H. G. Patch-clamp '
'study of hepatitis C p7 channels reveals genotype-specific sensitivity '
'to inhibitors. Biophys. J. 110, 2419–2429 (2016).',
'journal-title': 'Biophys. J.'},
{ 'key': '31764_CR83',
'doi-asserted-by': 'publisher',
'first-page': '330',
'DOI': '10.1016/j.virol.2015.08.010',
'volume': '485',
'author': 'JL Nieto-Torres',
'year': '2015',
'unstructured': 'Nieto-Torres, J. L. et al. Severe acute respiratory syndrome coronavirus '
'E protein transports calcium ions and activates the NLRP3 inflammasome. '
'Virology 485, 330–339. https://doi.org/10.1016/j.virol.2015.08.010 '
'(2015).',
'journal-title': 'Virology'},
{ 'key': '31764_CR84',
'doi-asserted-by': 'publisher',
'first-page': '8865',
'DOI': '10.1096/fj.201802418R',
'volume': '33',
'author': 'KL Siu',
'year': '2019',
'unstructured': 'Siu, K. L. et al. Severe acute respiratory syndrome coronavirus ORF3a '
'protein activates the NLRP3 inflammasome by promoting TRAF3-dependent '
'ubiquitination of ASC. FASEB J. 33, 8865–8877. '
'https://doi.org/10.1096/fj.201802418R (2019).',
'journal-title': 'FASEB J.'},
{ 'key': '31764_CR85',
'doi-asserted-by': 'publisher',
'first-page': '1779',
'DOI': '10.1002/hep.22555',
'volume': '48',
'author': 'SD Griffin',
'year': '2008',
'unstructured': 'Griffin, S. D. et al. Genotype-dependent sensitivity of hepatitis C '
'virus to inhibitors of the p7 ion channel. Hepatology 48, 1779–1790 '
'(2008).',
'journal-title': 'Hepatology'},
{ 'issue': '18',
'key': '31764_CR86',
'doi-asserted-by': 'publisher',
'first-page': '4580',
'DOI': '10.1021/acs.jafc.5b00312',
'volume': '63',
'author': 'T Kongpichitchoke',
'year': '2015',
'unstructured': 'Kongpichitchoke, T., Hsu, J.-L. & Huang, T.-C. Number of hydroxyl groups '
'on the B-ring of flavonoids affects their antioxidant activity and '
'interaction with phorbol ester binding site of PKCδ C1B domain: in vitro '
'and in silico studies. J. Agric. Food Chem. 63(18), 4580–4586. '
'https://doi.org/10.1021/acs.jafc.5b00312 (2015).',
'journal-title': 'J. Agric. Food Chem.'},
{ 'key': '31764_CR87',
'doi-asserted-by': 'publisher',
'first-page': '162750',
'DOI': '10.1155/2013/162750',
'volume': '2013',
'author': 'S Kumar',
'year': '2013',
'unstructured': 'Kumar, S. & Pandey, A. K. Chemistry and biological activities of '
'flavonoids: an overview. Sci.WorldJ. 2013, 162750. '
'https://doi.org/10.1155/2013/162750 (2013).',
'journal-title': 'Sci.WorldJ.'},
{ 'key': '31764_CR88',
'doi-asserted-by': 'publisher',
'first-page': '712',
'DOI': '10.1016/j.bbadis.2016.12.006',
'volume': '1863',
'author': 'NS Farag',
'year': '2017',
'unstructured': 'Farag, N. S., Breitinger, U., El-Azizi, M. & Breitinger, H. G. The p7 '
'viroporin of the hepatitis C virus contributes to liver inflammation by '
'stimulating production of Interleukin-1β. Biochim. Biophys. Acta Mol. '
'Basis Dis. 1863, 712–720 (2017).',
'journal-title': 'Biochim. Biophys. Acta Mol. Basis Dis.'},
{ 'key': '31764_CR89',
'doi-asserted-by': 'publisher',
'first-page': '675287',
'DOI': '10.3389/fphar.2021.675287',
'volume': '12',
'author': 'BAC Rattis',
'year': '2021',
'unstructured': 'Rattis, B. A. C., Ramos, S. G. & Celes, M. R. N. Curcumin as a potential '
'treatment for COVID-19. Front. Pharmacol. 12, 675287. '
'https://doi.org/10.3389/fphar.2021.675287 (2021).',
'journal-title': 'Front. Pharmacol.'},
{ 'key': '31764_CR90',
'doi-asserted-by': 'publisher',
'first-page': '19963',
'DOI': '10.1038/s41598-020-77003-3',
'volume': '10',
'author': 'P Kanjanasirirat',
'year': '2020',
'unstructured': 'Kanjanasirirat, P. et al. High-content screening of Thai medicinal '
'plants reveals Boesenbergia rotunda extract and its component Panduratin '
'A as anti-SARS-CoV-2 agents. Sci. Rep. 10, 19963 (2020).',
'journal-title': 'Sci. Rep.'},
{ 'key': '31764_CR91',
'doi-asserted-by': 'publisher',
'author': 'PK Agrawal',
'year': '2020',
'unstructured': 'Agrawal, P. K., Agrawal, C. & Blunden, G. Quercetin: antiviral '
'significance and possible COVID-19 integrative considerations. Nat. '
'Prod. Comm. https://doi.org/10.1177/1934578X20976293 (2020).',
'journal-title': 'Nat. Prod. Comm.',
'DOI': '10.1177/1934578X20976293'},
{ 'key': '31764_CR92',
'doi-asserted-by': 'publisher',
'first-page': '5325',
'DOI': '10.1002/jcp.30233',
'volume': '236',
'author': 'S Tahmasebi',
'year': '2020',
'unstructured': 'Tahmasebi, S. et al. Immunomodulatory effects of nanocurcumin on Th17 '
'cell responses in mild and severe COVID-19 patients. J. Cell Physiol. '
'236, 5325–5338 (2020).',
'journal-title': 'J. Cell Physiol.'},
{ 'key': '31764_CR93',
'doi-asserted-by': 'publisher',
'first-page': '104451',
'DOI': '10.1016/j.meegid.2020.104451',
'volume': '84',
'author': 'D Bhowmik',
'year': '2020',
'unstructured': 'Bhowmik, D. et al. Identification of potential inhibitors against '
'SARS-CoV-2 by targeting proteins responsible for envelope formation and '
'virion assembly using docking based virtual screening, and '
'pharmacokinetics approaches. Infect. Genet. Evol. 84, 104451. '
'https://doi.org/10.1016/j.meegid.2020.104451 (2020).',
'journal-title': 'Infect. Genet. Evol.'},
{ 'key': '31764_CR94',
'doi-asserted-by': 'publisher',
'first-page': '16674',
'DOI': '10.1007/s10668-021-01373-5',
'volume': '23',
'author': 'HS Mahrosh',
'year': '2021',
'unstructured': 'Mahrosh, H. S. & Mustafa, G. An in silico approach to target '
'RNA-dependent RNA polymerase of COVID-19 with naturally occurring '
'phytochemicals. Environ. Dev. Sustain. 23, 16674–16687. '
'https://doi.org/10.1007/s10668-021-01373-5 (2021).',
'journal-title': 'Environ. Dev. Sustain.'}],
'container-title': 'Scientific Reports',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.nature.com/articles/s41598-023-31764-9.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.nature.com/articles/s41598-023-31764-9',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.nature.com/articles/s41598-023-31764-9.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2023, 4, 3]],
'date-time': '2023-04-03T05:58:06Z',
'timestamp': 1680501486000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.nature.com/articles/s41598-023-31764-9'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2023, 4, 1]]},
'references-count': 94,
'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2023, 12]]}},
'alternative-id': ['31764'],
'URL': 'http://dx.doi.org/10.1038/s41598-023-31764-9',
'relation': {},
'ISSN': ['2045-2322'],
'subject': ['Multidisciplinary'],
'container-title-short': 'Sci Rep',
'published': {'date-parts': [[2023, 4, 1]]},
'assertion': [ { 'value': '28 September 2022',
'order': 1,
'name': 'received',
'label': 'Received',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': '16 March 2023',
'order': 2,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': '1 April 2023',
'order': 3,
'name': 'first_online',
'label': 'First Online',
'group': {'name': 'ArticleHistory', 'label': 'Article History'}},
{ 'value': 'The authors declare no competing interests.',
'order': 1,
'name': 'Ethics',
'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}],
'article-number': '5328'}
